Literature DB >> 32390106

Comparison of clinical outcomes following early rehabilitation in 3 cases of nephrotic syndrome with different treatment courses.

Kohji Iwai1, Yasuhiko Hatanaka2, Tamiro Kawaguchi3, Shin-Ich Araki4.   

Abstract

There have been few published reports regarding rehabilitation for nephrotic syndrome. We compared the clinical outcomes of three cases of nephrotic syndrome with different treatment courses during 5 weeks of early rehabilitation.We report on three cases of nephrotic syndrome. Case 1 was a 67-year-old male who showed good progress after steroid treatment. Quadriceps torque and exercise capacity were increased after intervention. Case 2, a 78-year-old male, demonstrated resistance to steroid treatment. Quadriceps torque was decreased and exercise capacity was increased after intervention. Case 3 was an 83-year-old male who received nutrition therapy and diuretics without steroid treatment. Quadriceps torque and exercise capacity were decreased post-intervention.Early rehabilitation should be considered even if the steroid treatment course is different; furthermore, it is necessary to carefully consider the optimal exercise load in patients with nephrotic syndrome for whom regardless of whether or not steroid treatment is used.

Entities:  

Year:  2020        PMID: 32390106     DOI: 10.1007/s13730-020-00486-6

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  2 in total

1.  Effectiveness and safety of rehabilitation on minimal change nephrotic syndrome in remission for elderly patients with low activity of daily living: a case report.

Authors:  Ren Takahashi; Hiroki Yabe; Takashi Hibino; Sayumi Morishita; Hideaki Ishikawa
Journal:  CEN Case Rep       Date:  2021-10-08

2.  Effectiveness and Safety of Rehabilitation for Pediatric Patients with Nephrotic Syndrome in the Acute Phase: A Case Study.

Authors:  Aki Tabata; Hiroki Yabe; Yuya Mitake; Tomohiro Shirai; Marina Yoshida; Rie Kurosu; Ken Kawamura
Journal:  Prog Rehabil Med       Date:  2022-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.